BridgeMD
New treatment option for Primary Dysmenorrhea
Official title Exercise, Motor Imagery, and Pain Neuroscience Education for Primary Dysmenorrhea: A Randomized Trial
ClinicalTrials.gov ID: NCT07196150
What this study is testing
- What it's testing
- The goal of this clinical trial is to find out whether exercise, motor imagery training, and pain neuroscience education can help reduce menstrual pain and improve well-being in young women with primary dysmenorrhea. The study will also look at how these approaches affect menstrual symptoms, movement control, and cognitive flexibility.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25, women only
You may be able to join if
- Female, aged 18-25 years
- Gynecological examination and ultrasound confirming absence of pelvic pathology
- History of primary dysmenorrhea for at least 6 months, with pain intensity ≥4 on the Numeric Rating Scale (0-10) during the first 3 days of...
- Regular menstrual cycles (21-35 days)
- Nulliparous (no history of pregnancy or childbirth)
You likely can't join if
- Diagnosis of secondary dysmenorrhea (e.g., endometriosis, pelvic inflammatory disease, uterine fibroids, ovarian cysts)
- Current pregnancy or planning to become pregnant during the study period
- History of pelvic or abdominal surgery
- History of sexually transmitted diseases
- Current use of antidepressants, anxiolytics, or hormonal therapy (e.g., oral contraceptives, intrauterine device)
- Known neurological, psychiatric, or systemic musculoskeletal disorders
See the full eligibility criteria
- Female, aged 18-25 years
- Gynecological examination and ultrasound confirming absence of pelvic pathology
- History of primary dysmenorrhea for at least 6 months, with pain intensity ≥4 on the Numeric Rating Scale (0-10) during the first 3 days of menstruation
- Regular menstrual cycles (21-35 days)
- Nulliparous (no history of pregnancy or childbirth)
- No systemic, metabolic, rheumatologic, or lumbar pathology
- Willingness to participate in the 8-week intervention program and attend follow-up assessments
- Diagnosis of secondary dysmenorrhea (e.g., endometriosis, pelvic inflammatory disease, uterine fibroids, ovarian cysts)
- Current pregnancy or planning to become pregnant during the study period
- History of pelvic or abdominal surgery
- History of sexually transmitted diseases
- Current use of antidepressants, anxiolytics, or hormonal therapy (e.g., oral contraceptives, intrauterine device)
- Known neurological, psychiatric, or systemic musculoskeletal disorders
- Cognitive impairment or attention deficit that may interfere with participation
- Participation in regular exercise in the last 6 months
- Use of alternative therapies for dysmenorrhea (e.g., acupuncture, massage)
The study team makes the final eligibility decision.
Where it's taking place
- Aydin, Efeler, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aydin, Efeler, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.